Skip to content
Home› Europe› European Commission› Gazette› Commission Regulation (EU) 2024/261...
REGULATORY POLICY GAZETTE NOTIFICATION

Commission Regulation (EU) 2024/2612 of 7 October 2024 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for chitosan, clopyralid, difenoconazole, fat distillation residues, flonicamid, hydrolysed proteins, and lavandulyl senecioate in or on certain products

Date: 8th October 2024
Issued by European Commission · Directorate-General for Health and Food Safety
Jurisdiction: European Union
European Union

Read or download the official PDF of this gazette notification issued by the European Commission on 8th October 2024.

Official Gazette Notification Text

Official Transcript

Official Journal EN of the European Union L series 2024/2612 8.10.2024 COMMISSION REGULATION (EU) 2024/2612 of 7 October 2024 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for chitosan, clopyralid, difenoconazole, fat distillation residues, flonicamid, hydrolysed proteins, and lavandulyl senecioate in...

PolicyIndex Takeaway
Get AI summary →
  • ✓ Commission Regulation (EU) 2024/2612 amends Annexes II, III, and IV to Regulation (EC) No 396/2005. This regulation concerns the maximum residue levels (MRLs) for certain substances, including chitosan, clopyralid, difenoconazole, fat distillation residues, flonicamid, hydrolysed proteins, and lavandulyl senecioate, in or on specific products.
  • ✓ The regulation modifies MRLs for flonicamid in various fruits, vegetables, pulses, oilseeds, cereals, and products of animal origin, as specified in the amended Annex II.
  • ✓ The regulation modifies MRLs for clopyralid and difenoconazole in various fruits, vegetables, pulses, oilseeds, cereals, and products of animal origin, as specified in the amended Annex III.
  • ✓ Chitosan, hydrolysed proteins, fat distillation residues and lavandulyl senecioate are added to Annex IV, indicating that no specific MRLs are required for these substances due to their low-risk nature and conditions of use that are not expected to pose a risk to consumers.

You might also want to explore

Get daily policy updates in your inbox

Choose the sectors and regulators you care about. We'll send only what matters to you.

No spam. Unsubscribe anytime.